Evidence map›Paper›PMID 39448380›Full record

ArticleChemMedChem2025

Bushy-Tailed Multicationic Quaternary Phosphonium Compounds: Potent Amphiphilic Disinfectants with Promising Therapeutic Indices.

Diana Rachii, Elise L Bezold, William M Wuest, Kevin P C Minbiole

Abstract read
In one paragraph

Article in ChemMedChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Diana RachiiDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.
Elise L BezoldDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.
William M WuestDepartment of Chemistry, Emory University, Atlanta, GA, 30322, USA.ORCID https://orcid.org/0000-0002-5198-7744
Kevin P C MinbioleDepartment of Chemistry, Villanova University, Villanova, PA, 19085, USA.ORCID https://orcid.org/0000-0003-4263-9833

Funding

Natural Product-Inspired Approaches Toward The Development Of Antivirulence And Species-Specific InhibitorsR35GM119426 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI William M Wuest · 2016 to 2026
$4.8M
The Development of Novel Disinfectants to Overcome Bacterial ResistanceR15AI185860 · NIAID · VILLANOVA UNIVERSITY · PI MINBIOLE, KEVIN P · 2024 to 2024
$359k
Major Research Instrumentation grants from the National Science Foundation CHE-1827930 and CHE-2018399 to K.P.C.M.NIAID NIH HHS R15 AI185860NIGMS NIH HHS R15AI185860 to K. P. C. M.NIGMS NIH HHS R35 GM119426NIGMS NIH HHS R35GM119426 to W.M.W.
6 · The paper itself

Abstract

Quaternary ammonium compounds (QACs) have been essential for protecting human health for almost a century, functioning as surface disinfectants and sanitizers. With bacterial resistance increasing against commercially available QACs, the development of novel antimicrobials with divergent architectures is essential for effective infection prevention and control. Toward this end, our group has expanded beyond traditional ammonium scaffolds and explored the development of quaternary phosphonium compounds (QPCs). Herein, we report the synthesis and biological investigation of a series of 20 novel multicationic QPCs, bearing multiple short alkyl or aryl chains, also referred to as "bushy-tailed" multiQPCs; these structures were hypothesized to have strong bioactivity while displaying low mammalian toxicity. Select bushy-tailed QPC derivatives with trishexylphosphonium groups displayed single-digit or sub-micromolar activity against all seven bacteria tested, and MIC values of 2- to 8-fold better than their bushy-tailed QAC counterparts. Importantly, therapeutic indices of these bushy-tailed QPCs were favorable in many cases, and were ≥4 against the entire bacterial panel for pX-P6*,P6* and 1,8-P6*,P6*, superior to more traditional architectures. This work highlights the promise of a novel set of multicationic phosphonium compounds as novel disinfectants with potent bioactivities and low toxicity.

Indexed as

Anti-Bacterial AgentsDisinfectantsOrganophosphorus CompoundsQuaternary Ammonium CompoundsSurface-Active AgentsAnimalsDose-Response Relationship, DrugHumansMicrobial Sensitivity TestsMolecular StructureStructure-Activity RelationshipAnti-Bacterial AgentsDisinfectantsOrganophosphorus CompoundsQuaternary Ammonium CompoundsSurface-Active AgentsAmphiphilesCationic biocideDisinfectantsQPCQuaternary phosphonium compounds

Identifiers

PMID39448380
PMCPMC12048865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.